Asensus Surgical has entered into a definitive merger agreement with Karl Storz Endoscopy-America, a wholly owned direct subsidiary of Karl Storz. The transaction would enhance Karl Storz’s portfolio and market presence, strengthening the company’s position in the growing robotic surgical market, particularly with the development of the next generation LUNA system. The transaction has been unanimously approved by Asensus’ Board of Directors.
The LUNA system is designed to elevate the standards of robotic-assisted surgery. The system integrates carefully crafted hardware and software architecture to prioritize safety, reliability and performance. LUNA's features include a surgeon console with unconstrained handles, an interactive touchscreen, and an Ultra-HD 3D monitor.
Additionally, the system boasts up to four independent robotic manipulator arms for procedural flexibility, alongside a unique instrument drive system supporting various advanced instrumentation options
Asensus Surgical will work expeditiously to secure stockholder approval of the transaction and to close the transaction in accordance with the terms of the Merger Agreement. The transaction is anticipated to close during the third quarter of 2024, subject to customary closing conditions, including receipt of approval from the Asensus stockholders.
"We are pleased to have reached this agreement with Karl Storz, which we believe maximizes value for our stockholders,” said Anthony Fernando, Asensus Surgical President and CEO. “This transaction is a testament to the value of our innovative robotic and digital technology, intellectual property, and the hard work of our talented team. We are excited to enter the next chapter for Asensus with Karl Storz, which will allow us to continue to develop and deliver precise, safer, predictable surgery and digital tools to patients and surgeons around the world."
Kommentare